Search results for "Antihypertensive"

showing 10 items of 203 documents

AISF position paper on liver disease and pregnancy.

2016

Abstract The relationship between liver disease and pregnancy is of great clinical impact. Severe liver disease in pregnancy is rare; however, pregnancy-related liver disease is the most frequent cause of liver dysfunction during pregnancy and represents a severe threat to foetal and maternal survival. A rapid differential diagnosis between liver disease related or unrelated to pregnancy is required in women who present with liver dysfunction during pregnancy. This report summarizes the recommendation of an expert panel established by the Italian Association for the Study of the Liver (AISF) on the management of liver disease during pregnancy. The article provides an overview of liver disea…

Cholagogues and CholereticsViral HepatitisBudd-Chiari SyndromeChronic liver diseaseAdrenal Cortex HormoneGastroenterologyHyperemesis gravidarumLiver disease0302 clinical medicinePre-EclampsiaAdrenal Cortex HormonesCholelithiasisMED/12 - GASTROENTEROLOGIAPregnancyHyperemesis GravidarumEclampsiaCholelithiasiThiaminePregnancy Complications InfectiousCholagogues and CholereticSocieties Medical030219 obstetrics & reproductive medicineFatty liverUrsodeoxycholic AcidGastroenterologyCalcium Channel BlockersLiver diseases; Pregnancy; Gastroenterology; HepatologyPregnancy ComplicationAntihypertensive AgentItalyVitamin B ComplexBudd–Chiari syndromeLiver diseases; Pregnancy030211 gastroenterology & hepatologyFemaleCalcium Channel BlockerLiver diseaseHumanViral Hepatitis Vaccinesmedicine.medical_specialtyHELLP SyndromeHepatitis Viral HumanHELLP syndromeCholestasis Intrahepatic03 medical and health sciencesMagnesium SulfateInternal medicinemedicineHumansIntensive care medicineAntihypertensive AgentsLiver diseasesPregnancyEclampsiaHepatologybusiness.industrymedicine.diseasePregnancy ComplicationsFatty LiverPregnancy Liver disease Viral HepatitisPregnancy Complications InfectiouFluid TherapybusinessViral Hepatitis Vaccine
researchProduct

Performance of micellar mobile phases in reversed-phase chromatography for the analysis of pharmaceuticals containing beta-blockers and other antihyp…

1996

A rapid and simple reversed-phase micellar liquid chromatographic procedure for the simultaneous determination of the beta-blockers atenolol, metoprolol and oxprenolol, the diuretics amiloride, bendroflumethiazide, chlorthalidone and hydrochlorothiazide and the vasodilator hydralazine in pharmaceuticals, is proposed. An interpretive optimization procedure, which uses the chromatographic data for only five mobile phases, was applied to select a suitable micellar mobile phase. A comparative study was also made of the performance of micellar and aqueous-organic mobile phases in the analysis of pharmaceuticals that combine beta-blockers and diuretics. The determination of all the drugs could be…

ChromatographyAdrenergic beta-AntagonistsReversed-phase chromatographyAtenololHydralazineBiochemistryHigh-performance liquid chromatographyDosage formAnalytical Chemistrychemistry.chemical_compoundHydrochlorothiazidechemistryOxprenololElectrochemistrymedicineSolventsEnvironmental ChemistryBendroflumethiazideSodium dodecyl sulfateDiureticsSpectroscopyAntihypertensive AgentsChromatography High Pressure LiquidMicellesmedicine.drugThe Analyst
researchProduct

Evidences from Clinical Trials and Use of Antihypertensive Drugs in Children and Adolescents

2019

In adults, when prescribing antihypertensive therapy, decisions regarding the choice of agent can be based upon evidence from clinical trials in large numbers of subjects, many of these having compared one class of agent with another. Whilst increased emphases on conducting drug trials in children and adolescents over the past 25 years have yielded important advances, and have tested the efficacy and safety of the various classes of antihypertensive agents, there remains a general lack of high quality long-term outcome data to guide choice of drug therapy for pediatricians managing HTN. As of today, certain clinical trials in children and adolescents have established the pharmacokinetics, p…

Clinical trialmedicine.medical_specialtyDrug trialPharmacotherapybusiness.industryPharmacodynamicsMedicineOutcome databusinessIntensive care medicineAntihypertensive medication
researchProduct

2016 European Guidelines on cardiovascular disease prevention in clinical practice The Sixth Joint Task Force of the European Society of Cardiology a…

2016

ABI : ankle–brachial (blood pressure) index ABPM : ambulatory blood pressure monitoring ACCORD : Action to Control Cardiovascular Risk in Diabetes ACE-I : angiotensin-converting enzyme inhibitor ACS : acute coronary syndromes ADVANCE : Action in Diabetes and Vascular disease: PreterAx

Cost-Benefit AnalysisGeneral Practice030204 cardiovascular system & hematologyGuidelineDiabete0302 clinical medicineHyperlipidemiaStakeholderMedicine030212 general & internal medicineMultiple Chronic ConditionsPractice Patterns Physicians'Societies MedicalRisk assessmenteducation.field_of_studyCardiac RehabilitationDiabetesRehabilitationSmokingPsychosocial factorAge FactorsLipidMiddle AgedPrimary carePedigreeEuropeCardiovascular DiseasesPsychosocial factorsHypertensionBlood pressureDiet HealthyRisk assessmentCardiology and Cardiovascular MedicineAdultDiagnostic Imagingmedicine.medical_specialtyAmbulatory blood pressurePopulationPopulationCardiologyHealthy lifestyleHyperlipidemiasHealth PromotionDiabetic angiopathyGuidelinesRisk Assessment03 medical and health sciencesSex FactorsDiabetes mellitusJournal ArticleHumansClinical settingsHealthy LifestyleIntensive care medicineeducationExerciseAntihypertensive AgentsNutritionAgedbusiness.industryVascular diseasePhysical activityPreventionmedicine.diseasebody regionsClinical settingBlood pressureRisk managementSocioeconomic FactorsSmoking CessationJoint Esc GuidelinesbusinessBiomarkersDiabetic Angiopathies
researchProduct

Interpretation of epicardial mapping by means of computer simulations: Applications to calcium, lidocaine and to BRL 34915

1992

The aim of this work was to compare experimental investigations on effects of lidocaine, calcium and, BRL 34915 on reentries to simulated data obtained by use of a model of propagation based on the Huygens' construction method already described in previous works. Calcium and lidocaine effects are investigated on anisotropic conduction conditions. In both cases, reduction in conduction velocities are observed. In lidocaine case, a refractory area is located along the longitudinal axis. In agreement with experimental electrical mapping, the simulations show that the stabilization of reentrant excitation is mainly due to the existence of this refractory area around which the reentrant circuit …

CromakalimMaterials scienceLidocaineRefractory periodchemistry.chemical_elementCalciumGeneral Biochemistry Genetics and Molecular BiologyConstrictionDogsHeart Conduction SystemmedicineAnimalsTachycardia Atrioventricular Nodal ReentryBenzopyransComputer SimulationPyrrolesAntihypertensive AgentsGeneral Environmental ScienceApplied MathematicsModels CardiovascularLidocaineGeneral MedicineReentryMechanicsThermal conductionElectrophysiologyPhilosophyElectrophysiologyReentrancychemistryAnisotropyCalciumGeneral Agricultural and Biological Sciencesmedicine.drugActa Biotheoretica
researchProduct

Quantitation of talinolol in rat plasma by LC-MS-MS.

2010

The aim of this study was to develop and validate an assay based on liquid chromatography-tandem mass spectrometry to quantitate talinolol in rat plasma. After a simple protein precipitation step, separation was performed by reversed-phase liquid chromatography using gradient elution with acetonitrile-water-formic acid. Electrospray ionization in the positive ion mode with multiple reaction monitoring was used to analyze talinolol employing propranolol as internal standard. The calibration curve for talinolol was linear over the concentration range 1-250 ng/mL with a correlation coefficient0.995. The method was sensitive (limit of quantitation, 1 ng/mL) and had acceptable accuracy (85-115% …

Detection limitMaleSpectrometry Mass Electrospray IonizationChromatographyElectrospray ionizationSelected reaction monitoringAnalytical chemistryGeneral MedicineReversed-phase chromatographyMass spectrometryHigh-performance liquid chromatographyAnalytical ChemistryRatsPropanolamineschemistry.chemical_compoundchemistryProtein precipitationAnimalsRats WistarAntihypertensive AgentsChromatography High Pressure LiquidTalinololChromatography LiquidJournal of chromatographic science
researchProduct

Calixarene: A Versatile Material for Drug Design and Applications

2016

The therapy of various diseases by the drugs entrapped in calixarene derivatives is gaining attraction of researchers nowadays. Calixarenes are macrocyclic nano-baskets which belong to cavitands class of host-guest chemistry. They are the marvelous hosts with distinct hydrophobic three dimensional cavities to entrap and encapsulate biologically active guest drugs. Calixarene and its derivatives develop inclusion complexes with various types of drugs and vitamins for their sustained/targeted release. Calixarene and its derivatives are used as carriers for anti-cancer, anti-convulsant, anti-hypertensive, anthelmentic, anti-inflammatory, antimicrobial and antipsychotic drugs. They are the impo…

Drugmedia_common.quotation_subjectAnti-Inflammatory AgentsSupramolecular chemistrymacromolecular substances010402 general chemistry01 natural sciencesAnti-Infective AgentsDrug DiscoveryCalixareneHumansOrganic chemistryProdrugsAntihypertensive AgentsTargeted releasemedia_commonAnthelminticsPharmacologyDrug Carriers010405 organic chemistryChemistryProdrugBiocompatible material0104 chemical sciencesDrug DesignDrug releaseAnticonvulsantsCalixarenesAntipsychotic AgentsCurrent Pharmaceutical Design
researchProduct

Ion-pair approach coupled with nanoparticle formation to increase bioavailability of a low permeability charged drug.

2018

Abstract Atenolol is a drug widely used for the treatment of hypertension. However, the great drawback it presents is a low bioavailability after oral administration. To obtain formulations that allow to improve the bioavailability of this drug is a challenge for the pharmaceutical technology. The objective of this work was to increase the rate and extent of intestinal absorption of atenolol as model of a low permeability drug, developing a double technology strategy. To increase atenolol permeability an ion pair with brilliant blue was designed and the sustained release achieved through encapsulation in polymeric nanoparticles (NPs). The in vitro release studies showed a pH-dependent relea…

Drugmedia_common.quotation_subjectPharmaceutical ScienceAdministration OralBiological Availability02 engineering and technology030226 pharmacology & pharmacyIntestinal absorptionPermeability03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDrug Delivery SystemsPolylactic Acid-Polyglycolic Acid CopolymerIn vivoOral administrationmedicineAnimalsRats WistarAntihypertensive Agentsmedia_commonChromatographyChemistryBenzenesulfonates021001 nanoscience & nanotechnologyAtenololControlled releaseBioavailabilityPLGADrug LiberationAtenololIntestinal AbsorptionNanoparticles0210 nano-technologymedicine.drugInternational journal of pharmaceutics
researchProduct

Mechanisms underlying diabetes enhancement of endothelin-1-induced contraction in rabbit basilar artery

2004

The influence of alloxan-induced diabetes on the reactivity of rabbit basilar artery to endothelin-1 was examined. Endothelin-1 induced concentration-dependent contraction of basilar arteries that was higher in diabetic than in control rabbits. Endothelium removal produced a higher enhancement of the endothelin-1-induced contraction in control than in diabetic rabbits. N(G)-nitro-L-arginine (L-NOArg) enhanced the maximal contraction induced by endothelin-1 in control rabbits and potentiated this response in diabetic rabbits. Endothelin ETA receptor antagonist, cyclo(D-Asp-Pro-D-Val-Leu-D-Trp) (BQ-123), inhibited endothelin-1-induced contraction in both rabbit groups. Endothelin ETB receptor…

Endothelin Receptor AntagonistsMaleNitroprussidemedicine.medical_specialtyContraction (grammar)Vascular smooth muscleEndotheliumEndothelin A Receptor AntagonistsVasodilator AgentsEndothelin B Receptor AntagonistsNitroargininePeptides CyclicMuscle Smooth VascularDiabetes Mellitus ExperimentalPiperidinesIsometric Contractionmedicine.arteryInternal medicinemedicineBasilar arteryAnimalsEnzyme InhibitorsAntihypertensive AgentsPharmacologyDiabetisEndothelin-1Artèriesbusiness.industryEndoteli vascularReceptor Endothelin AReceptor Endothelin BEndothelin 1Òxid nítricEndothelin A Receptor AntagonistsEndothelin B Receptor AntagonistsEndocrinologymedicine.anatomical_structureBasilar Arterycardiovascular systemRabbitsbusinessEndothelin receptorOligopeptidesEuropean Journal of Pharmacology
researchProduct

Intravenous BQ-123 and phosphoramidon reduce ventricular ectopic beats and myocardial infarct size in dogs submitted to coronary occlusion and reperf…

2001

Abstract The aim of this work was to investigate the influence of endothelin on myocardial ischemia and reperfusion in anaesthetized dogs. Animals were submitted to left thoracotomy and 120 min of left anterior descending coronary occlusion, followed by 180 min of reperfusion. Arterial blood pressure and electrocardiogram (ECG) were recorded in order to analyze heart rate (HR)–pressure product and production of ectopic beats. Infarcted areas were identified by a macroscopic staining method and infarct size was expressed as percentage of risk zone. To inhibit the effects of endothelin in a group of animals, we administered intravenously an endothelin synthesis inhibitor (phosphoramidon) and …

Endothelin Receptor Antagonistsmedicine.medical_specialtyMyocardial InfarctionIschemiaBlood PressureCoronary DiseaseMyocardial ReperfusionPeptides Cyclicchemistry.chemical_compoundDogsInternal medicineHeart rateAnimalsMedicinecardiovascular diseasesMyocardial infarctionAntihypertensive AgentsPharmacologyBQ-123Endothelin-1Receptors Endothelinbusiness.industryPhosphoramidonGlycopeptidesReceptor Endothelin Amedicine.diseaseVentricular Premature ComplexesBlood pressurechemistryCoronary occlusionAnesthesiaInjections IntravenousVentricular Fibrillationcardiovascular systemCardiologyDrug Therapy CombinationbusinessEndothelin receptorGeneral Pharmacology: The Vascular System
researchProduct